Teva Pharmaceutical Industries reported $474M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Aspen Pharmacare ZAR 2.65B 3.41B Jun/2026
Cipla INR 13.88B 154.2M Sep/2026
Dr.Reddys Laboratories INR 8.6B 2.14B Jun/2026
Guangzhou Baiy CNY 2.31B 2.71B Mar/2026
Jiangsu Hengrui CNY 2.4B 159.2M Jun/2026
Kalbe Farma IDR 1.44T 141.07B Mar/2026
Richter Gedeon HUF 83.47B 692M Mar/2026
Sh Fosun Pharma CNY 1.65B 88.09M Mar/2026
Sun Pharmaceuticals INR 44.18B 4.63B Jun/2026
Teva Pharmaceutical Industries USD 474M 581M Jun/2026